ARCHIVES

Phase II Elotuzumab Study Demonstrates 33 Months PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Klausner Unveils New NCI Structure, Aims To Change Institute’s “Ethos”

August 11, 1995

Biopsies Could Be Reduced By Computer-Aided-Detection

December 26, 2003

In Brief: Stetten’s Deputy, Von Euler, Takes Over At NIGMS; Sherman’s Replacement Probably Will Be In-House

March 15, 1974

Minnesota Study Aimed At Finding Final Answer On Hemoccult Screening

July 24, 1987

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

EPIC, PLCO Studies Show High Fiber Diet Cuts Cancer Risk

May 2, 2003